Table 2 Treatment with anti-resorptive agents and intra-articular steroids injections during follow-up

	Treatment group
	Sequential monotherapy (n = 81)	Step-up combination therapy (n = 84)	Initial combination with prednisone (n = 89)	Initial combination with infliximab (n = 88)
Bisphosphonate use, % (n = 342)	9	8	27	6
No. of months used during follow-up†	9 (6–9)	8 (3–9)	9 (6–9)	6 (5–11)
Calcium supplement, % (n = 342)	21	18	39	21
No. of months used during follow-up†	9 (6–12)	9 (3–10)	9 (9–12)	9 (8–12)
Vitamin D supplement, % (n = 342)	9	12	23	8
No. of months used during follow-up†	9 (6–9)	9 (5–9)	9 (7–9)	9 (6–9)
Calcium and/or vitamin D, % (n = 342)	26	24	43	21
HRT use, % (n = 342)	14	13	16	17
No. of years used†	10 (3–17)	9 (2–15)	5 (3–11)	5 (1–10)
Intra-articular steroids injections (min. 1–max. 6), %	25	25	9	14